For the Inventor, By the Inventor

Enter assignee name

Affibody Ab

USPTO Granted Patents = 40

CIPO Patents = 2

EPO Patents = 30

Trademarks = 3

Forward Citations = 148

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Elin Gunneriusson (12 out of 19 patents)

Fredrik Frejd (10 out of 11 patents)

Joachim Feldwisch (9 out of 15 patents)

4. Christofer Lendel (9 out of 11 patents)

5. Lars Abrahmsén (9 out of 9 patents)

6. Nina Herne (8 out of 9 patents)

7. Caroline Ekblad (8 out of 8 patents)

8. Andreas Jonsson (6 out of 6 patents)

9. Lars B Abrahmsen (6 out of 18 patents)

10. Tove Eriksson (5 out of 5 patents)

11. Stefan Ståhl (4 out of 5 patents)

12. Lindvi Gudmundsdotter (4 out of 4 patents)

13. Malin Lindborg (4 out of 10 patents)

14. John Löfblom (4 out of 5 patents)

15. Torbjörn Gräslund (4 out of 4 patents)

Core Competencies:

IL-17A Associated Conditions

HER2 Binders

Binding Polypeptides

Polypeptide Libraries

Neonatal Fc Receptor Binding

Engineered Albumin Binding

Polypeptides Having Affinity for HER2

IGF-1R Binding Polypeptides

Affinity Separation

Protein A Derivatives

Staphylococcus Protein A Domain Mutants

In Vitro Selection of Polypeptides

40 patents: Sort by Forward Citations

1. 12221464 - Methods of treatment of IL-17A associated conditions (2025-02-11),

2. 11633507 - HER2 binders (2023-04-25),

3. RE49495 - Binding polypeptides having a mutated scaffold (2023-04-17),

4. 11505576 - Polypeptides based on a scaffold (2022-11-22),

5. 11155596 - Polypeptide (2021-10-26),

6. 10934335 - IL-17A-binding polypeptides (2021-03-02),

7. 10894097 - HER2 binders (2021-01-19),

8. 10669314 - Polypeptide (2020-06-02),

9. 10633423 - IL-6-binding polypeptide complex (2020-04-28),

10. 10562955 - Polypeptides (2020-02-18),

11. 10556933 - Polypeptide libraries with a predetermined scaffold (2020-02-11),

12. 10364280 - Polypeptide (2019-07-30),

13. 10329331 - Polypeptides (2019-06-25),

14. 10323066 - Neonatal Fc receptor binding dimer and methods of use (2019-06-18),

15. 10208128 - HER3 binding polypeptides (2019-02-19),

Affibody AB is a Swedish privately-held biotech company focused on developing next-generation biopharmaceuticals based on its proprietary technology platforms: Affibody® molecules and Albumod™. The company's innovative platforms enable the rapid generation of new drug candidates for diseases with high unmet medical needs, such as cancer, autoimmune and inflammatory diseases. Affibody AB has a strong pipeline of therapeutic programs in both preclinical and clinical stages.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

40 Patents

#6 in Solna

#163 in Sweden

#16,570 in the World

Affibody Ab

Forward Citations = 148

54 inventors:

Elin Gunneriusson (12 out of 19 patents)

Fredrik Frejd (10 out of 11 patents)

Joachim Feldwisch (9 out of 15 patents)

4. Christofer Lendel (9 out of 11 patents)

5. Lars Abrahmsén (9 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…